Literature DB >> 8236123

von Willebrand factor: structure and function.

D Meyer1, J P Girma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8236123

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  13 in total

1.  Desmopressin enhances the binding of plasma von Willebrand factor to collagen in plasmas from normal dogs and dogs with type I von Willebrand's disease.

Authors:  I B Johnstone
Journal:  Can Vet J       Date:  1999-09       Impact factor: 1.008

2.  Characterization of von Willebrand factor in primary pulmonary hypertension.

Authors:  M T Collados; J Sandoval; S López; F A Massó; A Páez; J R Borbolla; L F Montaño
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

3.  Problem behavior of dementia patients predicts low-grade hypercoagulability in spousal caregivers.

Authors:  Roland von Känel; Brent T Mausbach; Joel E Dimsdale; Paul J Mills; Thomas L Patterson; Sonia Ancoli-Israel; Michael G Ziegler; Susan K Roepke; Matthew Allison; Igor Grant
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-05-19       Impact factor: 6.053

4.  Sea star tenacity mediated by a protein that fragments, then aggregates.

Authors:  Elise Hennebert; Ruddy Wattiez; Mélanie Demeuldre; Peter Ladurner; Dong Soo Hwang; J Herbert Waite; Patrick Flammang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

5.  Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure.

Authors:  Roland von Känel; José S Loredo; Sonia Ancoli-Israel; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

6.  Intracellular trafficking of factor VIII to von Willebrand factor storage granules.

Authors:  J B Rosenberg; P A Foster; R J Kaufman; E A Vokac; M Moussalli; P A Kroner; R R Montgomery
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

7.  Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin.

Authors:  M F Hoylaerts; K Nuyts; K Peerlinck; H Deckmyn; J Vermylen
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

8.  Structure, functional regulation and signaling properties of Rap2B.

Authors:  Debao Qu; Hui Huang; Jiehui DI; Keyu Gao; Zheng Lu; Junnian Zheng
Journal:  Oncol Lett       Date:  2016-02-23       Impact factor: 2.967

9.  Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains.

Authors:  Monica Sacco; Stefano Lancellotti; Mattia Ferrarese; Francesco Bernardi; Mirko Pinotti; Maira Tardugno; Erica De Candia; Leonardo Di Gennaro; Maria Basso; Betti Giusti; Massimiliano Papi; Giordano Perini; Giancarlo Castaman; Raimondo De Cristofaro
Journal:  Blood Adv       Date:  2020-07-28

10.  Pathologic Shear and Elongation Rates Do Not Cause Cleavage of Von Willebrand Factor by ADAMTS13 in a Purified System.

Authors:  Maria Bortot; Alireza Sharifi; Katrina Ashworth; Faye Walker; Allaura Cox; Katherine Ruegg; Nathan Clendenen; Keith B Neeves; David Bark; Jorge Di Paola
Journal:  Cell Mol Bioeng       Date:  2020-07-17       Impact factor: 2.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.